| Literature DB >> 36168606 |
Paige K Dekker1, Salma A Abdou1, Richard Youn1, Jenna C Bekeny1, Kevin G Kim1, Elizabeth G Zolper1, Kenneth L Fan1, Karen K Evans1.
Abstract
Vascular microanastomosis is technically challenging in patients with calcified recipient and donor vessels. Inside-to-outside suturing can prevent plaque rupture and ensure full-thickness intimal approximation. Although this is the preferred technique for anastomosis of atherosclerotic vessels, direct connection of calcified arteries necessitates outside-to-inside suturing on one side of the anastomosis. Furthermore, it is difficult to achieve optimal vessel wall approximation in the setting of luminal size mismatch and rigid vasculature. We previously reported on the use of a saphenous vein interposition graft as a novel technique to achieve a flow-sparing anastomosis in patients with diffuse atherosclerosis who are undergoing free tissue transfer. This study further assesses outcomes of this technique in a series of patients and demonstrates a flap success rate of over 93% in patients with calcified recipient and donor microvasculature.Entities:
Year: 2022 PMID: 36168606 PMCID: PMC9509154 DOI: 10.1097/GOX.0000000000004536
Source DB: PubMed Journal: Plast Reconstr Surg Glob Open ISSN: 2169-7574
Fig. 1.All arterial anastomoses were performed in an end-to-end fashion between the flap artery and the proximal end of the saphenous vein interposition graft, followed by an end-to-side anastomosis between the distal end of the saphenous vein interposition graft and the recipient artery.
Characteristics of Included Cases
| Patient | Age (y) | Sex | CCI | DM | PVD | CKD | Wound Etiology | VRO Pre | VRO Post | Type of Flap | Recipient Vessel | Ischemia Time (min) | Flap Success | Follow-up (mo) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 49 | F | 5 | Yes | Yes | Yes | Arterial | 1 | 1 | VL | AT | 114 | Yes | 15.8 |
| 2 | 72 | M | 5 | Yes | No | No | Diabetic | 2 | 2 | VL | AT | NR | Yes | 33.7 |
| 3 | 75 | M | 8 | Yes | Yes | Yes | Arterial | 0 | 1 | ALT | AT | 29 | No | 8.1 |
| 4 | 60 | M | 5 | Yes | No | Yes | Diabetic | 2 | 2 | ALT | PT | 90 | Yes | 20.3 |
| 5 | 59 | M | 2 | Yes | No | No | Diabetic | 2 | 2 | Chimeric (ALT + VL) | AT | 86 | Yes | 0.4 |
| 6 | 58 | M | 5 | Yes | No | Yes | Diabetic | 3 | 3 | VL | AT | NR | Yes | 14.0 |
| 7 | 73 | M | 8 | Yes | Yes | No | Arterial | 3 | 3 | VL | PT | 35 | Yes | 3.7 |
| 8 | 68 | M | 4 | Yes | Yes | No | Arterial | 2 | 2 | VL | PT | 52 | Yes | 12.1 |
| 9 | 54 | M | 6 | Yes | Yes | Yes | Diabetic | 1 | 2 | VL | PT | 102 | Yes | 17.3 |
| 10 | 43 | M | 5 | Yes | Yes | Yes | Arterial | 3 | 3 | VL | AT | 38 | Yes | 13.9 |
| 11 | 41 | M | 2 | Yes | No | No | Diabetic | 3 | 3 | ALT | PT | 42 | Yes | 11.4 |
| 12 | 61 | M | 6 | Yes | Yes | No | Arterial | 1 | 2 | ALT | AT | 120 | Yes | 0.7 |
| 13 | 79 | M | 6 | Yes | Yes | No | Diabetic | 1 | 2 | Chimeric (ALT + VL) | PT | 82 | Yes | 0.5 |
| 14 | 61 | M | 6 | Yes | Yes | No | Diabetic | 2 | 3 | ALT | PT | 71 | Yes | 2.1 |
| 15 | 70 | F | 4 | Yes | No | No | Diabetic | 2 | 2 | ALT | AT | NR | Yes | 0.7 |
*DM with end-organ damage.
†Uncomplicated DM.
‡Ultimately required amputation due to the development of new wounds or recurrent infection (not due to flap failure).
§Required takeback on POD 5 for arterial thrombus.
∥Required revision of arterial anastomosis during index operation.
CCI, Charlson comorbidity index; CKD, chronic kidney disease; DM, diabetes mellitus; PVD, peripheral vascular disease.